Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
-
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
-
Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024
-
Equity Stock Transfer teams up with Newsmax Inc. for historic IPO opening on New York Stock Exchange’s main board
-
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
-
Applied Digital Sets Fiscal Third Quarter 2025 Conference Call for Monday, April 14, 2025, at 5:00 p.m. Eastern Time
-
Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results
-
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
-
Progress Announces First Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
-
Revolution Medicines to Participate in April 2025 Investor Conferences
-
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results
-
Open Lending Announces Leadership Changes
-
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
-
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
-
American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Bank OZK Announces Date for First Quarter 2025 Earnings Release and Conference Call
-
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
-
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
-
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
Helport AI Reports First Half Fiscal Year 2025 Financial Results
-
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
-
SAML Announces Strategic Review and Operational Streamlining of Public Safety Businesses and Shareholder Meeting Date.
-
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
-
Red Cat Holdings Reports Financial Results for the 2024 Transition Period (as of December 31, 2024 and the eight months then ended) and Provides Corporate Update
-
Yoshiharu Regains Compliance with NASDAQ Stockholders’ Equity Requirement
-
GDEV announces results for the fourth quarter and full year 2024
-
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
-
Gray Announces AR Securitization Facility increase to $400 million and extension to 2028 and Revolving Credit Facility increase to $700 million
-
Kirby Corporation Announces Date for 2025 First Quarter Earnings Release and Earnings Webcast
-
Gleim Aviation Launches Revolutionary Digital Pilot Examiner, Gleim DPE™
-
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
-
Saskatchewan’s 6% PST on Vaping Undermines Harm Reduction, Fuels Illicit Market
-
Casino Group: Information regarding buy-out of minority shareholders of Cnova N.V.
-
Degree Wellness® Celebrates Awarding 100th Franchise Territory
-
VCU Health opens a new 39-bed unit for comprehensive liver care
-
PDAC urges swift, long-term METC extension to bolster Canada’s mineral exploration potential
-
Nokia Corporation: Repurchase of own shares on 31.03.2025
-
Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 31 March 2025
-
Credtent Announces $17-20 Million Dollar Valuation of Studio Ghibli's IP for AI Training and Advocates for Creative Consent
-
Credtent Announces $17-20 Million Dollar Valuation of Studio Ghibli's IP for AI Training and Advocates for Creative Consent
-
OWL BADGES ISSUES NEW REPORT ON HOW OFFICIAL BADGES FOSTER TRUST BETWEEN PUBLIC SAFETY OFFICERS AND CITIZENS
-
Baltic Horizon Fund consolidated audited results for 2024
-
Alamos Gold Provides Notice of Completion of Annual Filings
-
Local Art Project, CBH Hearts Across the Valley, is Gaining Traction and is in search of Artists
-
HOPSCOTCH GROUPE : Annual Results 2024
